Introduction
Temporary transvenous pacing is routinely used for patients with drug-resistant symptomatic bradycardia complicating acute myocardial infarction. The 
Discussion
Trans-oesophageal cardiac pacing was originally studied by Shafiroff and Linder (1957) and has subsequently been shown not to cause damage to the oesophageal mucosa (Burack and Furman, 1969; Lubell, 1971) . The first clinical application was by Burack and Furman but since then there have been only 2 reports in the literature regarding its successful use in the management of dangerous bradyarrhythmias. The technique of trans-oesophageal cardiac pacing has been described elsewhere (Hale et al., 1980) . The Vygon system used in these cases comprises a bipolar oesophageal electrode in conjunction with an amplifier and standard pacing box. The procedure is safe, simple and short, requiring neither special skills, aseptic technique nor X-ray screening. It 
